Compile Data Set for Download or QSAR
Report error Found 48 Enz. Inhib. hit(s) with all data for entry = 11728
TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642834BDBM642834(US11858905, Compound 34)
Affinity DataIC50: 0.600nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642843BDBM642843(US11858905, Compound 43)
Affinity DataIC50: 0.800nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642846BDBM642846(US11858905, Compound 46)
Affinity DataIC50: 1nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642835BDBM642835(US11858905, Compound 35)
Affinity DataIC50: 1.10nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642829BDBM642829(US11858905, Compound 29)
Affinity DataIC50: 1.30nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642826BDBM642826(US11858905, Compound 26)
Affinity DataIC50: 1.40nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642840BDBM642840(US11858905, Compound 40)
Affinity DataIC50: 1.5nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642839BDBM642839(US11858905, Compound 39)
Affinity DataIC50: 1.60nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642838BDBM642838(US11858905, Compound 38)
Affinity DataIC50: 1.70nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642845BDBM642845(US11858905, Compound 45)
Affinity DataIC50: 2.5nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642833BDBM642833(US11858905, Compound 33)
Affinity DataIC50: 2.90nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642848BDBM642848(US11858905, Compound 48)
Affinity DataIC50: 3.5nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642813BDBM642813(US11858905, Compound 13)
Affinity DataIC50: 3.90nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642820BDBM642820(US11858905, Compound 20)
Affinity DataIC50: 4.20nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642842BDBM642842(US11858905, Compound 42)
Affinity DataIC50: 4.5nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642822BDBM642822(US11858905, Compound 22)
Affinity DataIC50: 5.30nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642841BDBM642841(US11858905, Compound 41)
Affinity DataIC50: 5.30nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642803BDBM642803(US11858905, Compound 3)
Affinity DataIC50: 5.90nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642847BDBM642847(US11858905, Compound 47)
Affinity DataIC50: 6.60nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642806BDBM642806(US11858905, Compound 6)
Affinity DataIC50: 7nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642802BDBM642802(US11858905, Compound 2)
Affinity DataIC50: 7.5nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642821BDBM642821(US11858905, Compound 21)
Affinity DataIC50: 8.20nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642827BDBM642827(US11858905, Compound 27)
Affinity DataIC50: 8.5nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642824BDBM642824(US11858905, Compound 24)
Affinity DataIC50: 9.70nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642831BDBM642831(US11858905, Compound 31)
Affinity DataIC50: 11.7nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642828BDBM642828(US11858905, Compound 28)
Affinity DataIC50: 12.3nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642801BDBM642801(US11858905, Compound 1)
Affinity DataIC50: 14.1nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642844BDBM642844(US11858905, Compound 44)
Affinity DataIC50: 16.5nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642808BDBM642808(US11858905, Compound 8)
Affinity DataIC50: 17.4nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642815BDBM642815(US11858905, Compound 15)
Affinity DataIC50: 19.4nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642807BDBM642807(US11858905, Compound 7)
Affinity DataIC50: 21.1nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642809BDBM642809(US11858905, Compound 9)
Affinity DataIC50: 30.5nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642804BDBM642804(US11858905, Compound 4)
Affinity DataIC50: 34.9nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642825BDBM642825(US11858905, Compound 25)
Affinity DataIC50: 36.7nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642819BDBM642819(US11858905, Compound 19)
Affinity DataIC50: 44.6nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642818BDBM642818(US11858905, Compound 18)
Affinity DataIC50: 50.7nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642810BDBM642810(US11858905, Compound 10)
Affinity DataIC50: 51.5nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642836BDBM642836(US11858905, Compound 36)
Affinity DataIC50: 79.3nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642811BDBM642811(US11858905, Compound 11)
Affinity DataIC50: 94.6nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642805BDBM642805(US11858905, Compound 5)
Affinity DataIC50: 122nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642830BDBM642830(US11858905, Compound 30)
Affinity DataIC50: 124nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642837BDBM642837(US11858905, Compound 37)
Affinity DataIC50: 125nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642816BDBM642816(US11858905, Compound 16)
Affinity DataIC50: 139nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642817BDBM642817(US11858905, Compound 17)
Affinity DataIC50: 201nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642812BDBM642812(US11858905, Compound 12)
Affinity DataIC50: 235nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642823BDBM642823(US11858905, Compound 23)
Affinity DataIC50: 361nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642814BDBM642814(US11858905, Compound 14)
Affinity DataIC50: 534nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent

TargetProcathepsin L(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 642832BDBM642832(US11858905, Compound 32)
Affinity DataIC50: 1.00E+3nMAssay Description:Human cathepsin L enzymatic assay was performed in assay buffer (50 mM MES pH 5.5, 2.5 mM DTT, 0.5 mM EDTA) to assess the inhibition of human CatL by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2024
Entry Details
US Patent